ResMed, Inc. Stock Deutsche Boerse AG
Stocks
RME
US7611521078
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 173.05 EUR | -0.12% |
|
+5.61% | -15.63% |
| 06-22 | KeyBanc Adjusts Price Target on ResMed to $266 From $290, Maintains Overweight Rating | MT |
| 06-17 | ResMed Shares Fall After Morgan Stanley Downgrade | MT |
| Market Cap | 28.93B 25.36B 23.38B 21.89B 41.04B 2,729B 41.89B 281B 109B 1,349B 109B 106B 4,676B | P/E 2026 * |
18.9x | P/E 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 28.07B 24.61B 22.68B 21.24B 39.82B 2,648B 40.65B 273B 105B 1,309B 105B 103B 4,537B | EV / Sales 2026 * |
4.97x | EV / Sales 2027 * | 4.49x |
| Free-Float |
75.61% | Yield 2026 * |
1.21% | Yield 2027 * | 1.34% |
Last Transcript: ResMed, Inc.
| 1 day | -0.12% | ||
| 1 week | +5.61% | ||
| Current month | +1.05% | ||
| 1 month | -2.84% | ||
| 3 months | -11.19% | ||
| 6 months | -16.96% | ||
| Current year | -15.63% |
| 1 week | 163.3 |  | 175.15 |
| 1 month | 155.7 | | 176.75 |
| Current year | 155.7 | | 236.3 |
| 1 year | 155.7 | | 250.2 |
| 3 years | 126.4 | | 250.2 |
| 5 years | 126.4 | | 255.5 |
| 10 years | 50.46 | | 255.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 01/03/2013 |
Aaron Bloomer
DFI | Director of Finance/CFO | 40 | 04/05/2026 |
Jim Ellis
CMP | Compliance Officer | - | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CHM | Chairman | 53 | 25/01/2023 |
Ron Taylor
BRD | Director/Board Member | 78 | 01/01/2005 |
Peter Farrell
CHM | Chairman | 83 | 01/06/1989 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | +5.61% | - | - | 28.93B | |
| +1.44% | +10.42% | +24.49% | -1.72% | 191B | |
| +1.25% | -0.51% | -24.24% | +24.46% | 143B | |
| +1.75% | +10.74% | -2.62% | -17.53% | 139B | |
| +0.07% | -2.34% | -57.71% | -17.33% | 65.74B | |
| +1.18% | +3.91% | +17.67% | +1.44% | 52.27B | |
| -0.52% | -0.03% | -26.94% | -32.29% | 43.55B | |
| +0.37% | +7.04% | +13.89% | +14.90% | 38.41B | |
| -0.66% | +5.34% | +5.49% | +44.15% | 36.76B | |
| +1.26% | +6.77% | -12.16% | -15.48% | 29.91B | |
| Average | +0.60% | +4.45% | -6.90% | +0.07% | 82.17B | |
| Weighted average by Cap. | +0.99% | +5.19% | -3.84% | +0.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.65B 4.95B 4.57B 4.28B 8.02B 533B 8.18B 54.89B 21.24B 263B 21.22B 20.76B 914B | 6.1B 5.34B 4.93B 4.61B 8.65B 575B 8.83B 59.22B 22.91B 284B 22.89B 22.39B 985B |
| Net income | 1.55B 1.36B 1.25B 1.17B 2.2B 146B 2.24B 15.04B 5.82B 72.2B 5.82B 5.69B 250B | 1.7B 1.49B 1.37B 1.29B 2.41B 160B 2.46B 16.52B 6.39B 79.29B 6.39B 6.25B 275B |
| Net Debt | -859M -753M -694M -650M -1.22B -81.04B -1.24B -8.35B -3.23B -40.05B -3.23B -3.16B -139B | -1.58B -1.38B -1.28B -1.19B -2.24B -149B -2.28B -15.32B -5.93B -73.55B -5.92B -5.79B -255B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | €173.05 | -0.12% | 0 |
| 25/06/26 | €173.25 | +3.34% | 6 |
| 24/06/26 | €167.65 | +1.73% | 0 |
| 23/06/26 | €164.80 | +0.92% | 2 |
| 22/06/26 | €163.30 | -0.34% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
- RME Stock
Select your edition
All financial news and data tailored to specific country editions
